HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shinohara, H. Articles by Yamanashi, Y. Search for Related Content PubMed PubMed Citation Articles by Shinohara, H. Articles by Yamanashi, Y.

Hisaaki Shinohara^1,, Tomoharu Yasuda^1, and Yuji Yamanashi^1,2,*

¹ Department of Cell Regulation, Medical Research Institute, and ² School of Biomedical Science, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan

Dok-1 is a common substrate of many protein tyrosine kinases (PTKs). It recruits rasGAP and other SH2-containing proteins and negatively regulates Ras-Erk signalling downstream of PTKs. However, the mechanisms of its inhibitory effect are yet unclear. Here, a series of C-terminal deletion mutants of Dok-1 delineated the core domain for the inhibition of Erk from 334 to 346 amino acid, which contains two SH2-binding motifs having Tyr-336 or Tyr-340. The Dok-1 mutants having tyrosine-to-phenylalanine (YF) substitution(s) at Tyr-336 and/or Tyr-340 lost their inhibitory effect on Ras and Erk downstream of Src-like PTK, Lyn or Fyn, whereas the rasGAP-binding of each mutant remained intact. However, the Dok-1 mutant having YF substitutions at the rasGAP-binding sites (Tyr-295 and Tyr-361) also showed incapability of Ras and Erk inhibition. Moreover, the Dok-1 mutant having YF substitutions at Tyr-336 and Tyr-340 showed an impaired inhibitory effect on v-Abl-induced transformation of NIH-3T3 cells. These results demonstrate that Tyr-336 and Tyr-340 of Dok-1 are dispensable for rasGAP-binding but essential for inhibition of Ras-Erk signalling and cellular transformation downstream of PTKs. Thus, Dok-1 probably recruits as yet unidentified molecule(s), which, in concert with rasGAP, negatively regulate Ras-Erk signalling.

These authors contributed equally to this work.

Communicated by: Tadashi Yamamoto

^* Correspondence: E-mail: yamanashi.creg{at}mri.tmd.ac.jp

This article has been cited by other articles:

				M. Zhao, J. A. Janas, M. Niki, P. P. Pandolfi, and L. Van Aelst Dok-1 Independently Attenuates Ras/Mitogen-Activated Protein Kinase and Src/c-Myc Pathways To Inhibit Platelet-Derived Growth Factor-Induced Mitogenesis. Mol. Cell. Biol., April 1, 2006; 26(7): 2479 - 2489. [Abstract] [Full Text] [PDF]

				M. Honma, O. Higuchi, M. Shirakata, T. Yasuda, H. Shibuya, S.-i. Iemura, T. Natsume, and Y. Yamanashi Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases Genes Cells, February 1, 2006; 11(2): 143 - 151. [Abstract] [Full Text] [PDF]

				K. Shah and F. Vincent Divergent Roles of c-Src in Controlling Platelet-derived Growth Factor-dependent Signaling in Fibroblasts Mol. Biol. Cell, November 1, 2005; 16(11): 5418 - 5432. [Abstract] [Full Text] [PDF]

				T. Hiragun, Z. Peng, and M. A. Beaven Dexamethasone Up-Regulates the Inhibitory Adaptor Protein Dok-1 and Suppresses Downstream Activation of the Mitogen-Activated Protein Kinase Pathway in Antigen-Stimulated RBL-2H3 Mast Cells Mol. Pharmacol., March 1, 2005; 67(3): 598 - 603. [Abstract] [Full Text] [PDF]

				H. Shinohara, A. Inoue, N. Toyama-Sorimachi, Y. Nagai, T. Yasuda, H. Suzuki, R. Horai, Y. Iwakura, T. Yamamoto, H. Karasuyama, et al. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling J. Exp. Med., February 7, 2005; 201(3): 333 - 339. [Abstract] [Full Text] [PDF]